MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Department of Cellular Pathology, Oxford University Hospitals, NHS Foundation Trust, Oxford OX3 9DU, UK.
Cell Rep. 2021 May 25;35(8):109153. doi: 10.1016/j.celrep.2021.109153.
The ATPase p97 is a central component of the ubiquitin-proteasome degradation system. p97 uses its ATPase activity and co-factors to extract ubiquitinated substrates from different cellular locations, including DNA lesions, thereby regulating DNA repair pathway choice. Here, we find that p97 physically and functionally interacts with the MRE11-RAD50-NBS1 (MRN) complex on chromatin and that inactivation of p97 blocks the disassembly of the MRN complex from the sites of DNA damage upon ionizing radiation (IR). The inhibition of p97 function results in excessive 5'-DNA end resection mediated by MRE11 that leads to defective DNA repair and radiosensitivity. In addition, p97 inhibition by the specific small-molecule inhibitor CB-5083 increases tumor cell killing following IR both in vitro and in vivo. Mechanistically, this is mediated via increased MRE11 nuclease accumulation. This suggests that p97 inhibitors might be exploited to improve outcomes for radiotherapy patients.
p97 是泛素蛋白酶体降解系统的核心组成部分。p97 利用其 ATP 酶活性和辅助因子,从不同的细胞位置提取泛素化的底物,包括 DNA 损伤,从而调节 DNA 修复途径的选择。在这里,我们发现 p97 与染色质上的 MRE11-RAD50-NBS1(MRN)复合物在物理和功能上相互作用,并且 p97 的失活会阻止电离辐射(IR)后 MRN 复合物从 DNA 损伤部位解体。p97 功能的抑制导致 MRE11 介导的过度 5'-DNA 末端切除,导致 DNA 修复缺陷和放射敏感性。此外,特异性小分子抑制剂 CB-5083 抑制 p97 功能会增加 IR 后体外和体内肿瘤细胞的杀伤。从机制上讲,这是通过增加 MRE11 核酸酶的积累来介导的。这表明 p97 抑制剂可能被利用来改善放疗患者的治疗效果。